Event Details

Spark Therapeutics, Inc. at American Society of Gene & Cell Therapy 2017 Annual Meeting

Tuesday, May 9, 2017  through Saturday, May 13, 2017 
Title
Spark Therapeutics, Inc. at American Society of Gene & Cell Therapy 2017 Annual Meeting
Date / Time
05/09/17
Location
Marriott Wardman Park Hotel
Washington DC 
Description
  • Katherine A. High, M.D., president and chief scientific officer, will present on “Clinical-Development Pathways in Gene-based Therapeutics,” as part of the Clinical Pathways from Lab to (Almost) Licensure session on Tuesday, May 9, from 2:20 to 4 p.m. EDT
  • Xavier M. Anguela, Ph.D., head of discovery, will present “SPK-9001: Adeno-Associated Virus Mediated Gene Transfer for Hemophilia B at the Low Vector Dose Achieved Sustained, Continuous Factor IX Activity Levels Adequate for Endogenous Prophylaxis Preventing Bleeding Episodes and Reducing the Risk of Immune Response,” during the Clinical Trials Spotlight Symposium on Saturday, May 13, from 8:15 to 8:35 a.m. EDT.